Cargando…

Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer

Background: Effective biomarkers are essential to the differential diagnosis and severity assessment of non-small cell lung cancer (NSCLC). This study explored the use of the serum vascular endothelial growth factor (VEGF) levels as a biomarker with the aim of achieving better management of NSCLC. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Yanzhen, Wang, Xueping, Zeng, Tao, Xing, Shan, Dai, Shuqin, Wang, Junye, Chen, Shulin, Li, Xiaohui, Xie, Ying, Zhu, Yuanying, Liu, Wanli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950582/ https://www.ncbi.nlm.nih.gov/pubmed/29760791 http://dx.doi.org/10.7150/jca.23973

Ejemplares similares

Identification and Validation of Serum CST1 as a Diagnostic Marker for Differentiating Early-Stage Non-Small Cell Lung Cancer from Pulmonary Benign Nodules
por: Lai, Yanzhen, et al.
Publicado: (2022)

Protein Panel of Serum-Derived Small Extracellular Vesicles for the Screening and Diagnosis of Epithelial Ovarian Cancer
por: Lai, Huiling, et al.
Publicado: (2022)

Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients
por: Kong, Yanan, et al.
Publicado: (2013)

Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort study
por: Zhai, Wenyu, et al.
Publicado: (2020)

Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection
por: Chen, Shulin, et al.
Publicado: (2018)

An ultrasensitive hybridization chain reaction-amplified CRISPR-Cas12a aptasensor for extracellular vesicle surface protein quantification
por: Xing, Shan, et al.
Publicado: (2020)

The impact of an N1 lymph node examination in patients with early-stage non-small cell lung cancer: a retrospective cohort study
por: Zhai, Wenyu, et al.
Publicado: (2021)

A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients
por: Mao, Minjie, et al.
Publicado: (2018)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019)

The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion
por: Düzköprü, Yakup, et al.
Publicado: (2017)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2021)

Increased serum VEGF and b-FGF in Graves’ ophthalmopathy
por: Ye, Xiaozhen, et al.
Publicado: (2014)

Effect of Moxibustion on the Serum Levels of MMP-1, MMP-3, and VEGF in Patients with Rheumatoid Arthritis
por: Yu, Zeyun, et al.
Publicado: (2020)

Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF
por: Zhang, Xinyuan, et al.
Publicado: (2021)

Genetics of VEGF Serum Variation in Human Isolated Populations of Cilento: Importance of VEGF Polymorphisms
por: Ruggiero, Daniela, et al.
Publicado: (2011)

Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression
por: Wang, Huanyuan, et al.
Publicado: (2022)

Blood platelets and serum VEGF in cancer patients
Publicado: (1999)

Serum biomarkers VEGF-C and IL-6 are associated with severe human Peripheral Artery Stenosis
por: Chen, Jiexia, et al.
Publicado: (2015)

The Role of the VEGF Family in Coronary Heart Disease
por: Zhou, Yan, et al.
Publicado: (2021)

Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016)

Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review
por: Xu, Tao, et al.
Publicado: (2016)

Tumor Immune Microenvironment and Immunotherapy in Non-Small Cell Lung Cancer: Update and New Challenges
por: Xing, Shuqin, et al.
Publicado: (2022)

High-Density Lipoprotein Cholesterol Is a Favorable Prognostic Factor and Negatively Correlated with C-Reactive Protein Level in Non-Small Cell Lung Carcinoma
por: Chi, Pei-Dong, et al.
Publicado: (2014)

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance
por: Ma, Shaolin, et al.
Publicado: (2021)

Pathological response and serum VEGF changes during chemoradiotherapy for esophageal carcinoma
por: Wang, Jian, et al.
Publicado: (2019)

Evaluation of diagnostic and predictive values of the serum VEGF-A level and systemic immune-inflammation index in small cell lung cancer
por: Yao, Jing-hao, et al.
Publicado: (2021)

VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals
por: Yamakuchi, Munekazu, et al.
Publicado: (2023)

SAIF plays anti-angiogenesis via blocking VEGF-VEGFR2-ERK signal in tumor treatment
por: Xie, Junye, et al.
Publicado: (2023)

The Effect of Depression on Serum VEGF Level in Alzheimer's Disease
por: Jung, JaeHoon, et al.
Publicado: (2015)

A Nomogram based on Inflammatory Factors C-Reactive Protein and Fibrinogen to Predict the Prognostic Value in Patients with Resected Non-Small Cell Lung Cancer
por: Zeng, Qiuyao, et al.
Publicado: (2017)

The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer
por: Chen, Yao, et al.
Publicado: (2018)

Survivin and VEGF as Novel Biomarkers in Diagnosis of Endometriosis
por: Acimovic, Milena, et al.
Publicado: (2016)

Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma
por: Feng, Xinwei, et al.
Publicado: (2017)

Combination of serum matrix metalloproteinase-3 activity and EBV antibodies improves the diagnostic performance of nasopharyngeal carcinoma
por: Li, Yiqiu, et al.
Publicado: (2020)

Targeting regulation of VEGF by BPTF in non-small cell lung cancer and its potential clinical significance
por: Dai, Meng, et al.
Publicado: (2022)

Serum MiR-4687-3p Has Potential for Diagnosis and Carcinogenesis in Non-small Cell Lung Cancer
por: Liu, Man, et al.
Publicado: (2020)

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer
por: Iosifidou, R, et al.
Publicado: (2009)

Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer
por: Huang, Zhiliang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9mnh5kf0vcrp45ufompiso4vao